Global Dermatology Drug Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published: Aug, 2017 | Pages: 117 | Publisher: Data Market Research (DMR)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Dermatology Drug market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the Dermatology Drug market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Dermatology Drug market by By Route of Administration, By Form, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Dermatology Drug market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
    AbbVie (U.S.)
    Johnson & Johnson (U.S.)
    Bayer (Germany)
    Galderma (Switzerland)
    Bristol-Myers Squibb (U.S.)
    Novartis (China)
    Pfizer (U.S.)
    Merz Pharma (Germany)
    Valeant (Canada)
    LEO Pharma (Denmark)
    GlaxoSmithKline (UK)

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Dermatology Drug Market, by Route of Administration
    External Use
    Oral
    Injection
Dermatology Drug Market, by Form
    Ointment
    Liquid
    Powder
    Spray

Dermatology Drug Market, by Key Consumer
    Psoriasis
    Skin Infections
    Acne
    Dermatitis
    Other

 Table of Contents

Global Dermatology Drug Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

Chapter Two Dermatology Drug Market Overview
    2.1 Market Coverage
    2.2 Global Dermatology Drug Market Sales Volume Revenue and Price 2012-2017

Chapter Three Dermatology Drug by Key Players 2012-2017
    3.1 Global Dermatology Drug Sales Volume Market Share by Key Players 2012-2017
    3.2 Global Dermatology Drug Revenue Share by Key Players 2012-2017
    3.3 Global Key Players Dermatology Drug Key Product Model and Market Performance
    3.4 Global Key Players Dermatology Drug Key Target Consumers and Market Performance

Chapter Four Dermatology Drug by Regions 2012-2017
    4.1 Global Dermatology Drug Sales Market Share by Regions 2012-2017
    4.2 Global Dermatology Drug Revenue Market Share by Regions 2012-2017
    4.3 Global Dermatology Drug Price by Regions 2012-2017
    4.4 North America
        4.4.1 United States
        4.4.2 Canada
    4.5 Latin America
        4.5.1 Mexico
        4.5.2 Brazil
        4.5.3 Argentina
        4.5.4 Others in Latin America
    4.6 Europe
        4.6.1 Germany
        4.6.2 United Kingdom
        4.6.3 France
        4.6.4 Italy
        4.6.5 Spain
        4.6.6 Russia
        4.6.7 Netherland
        4.6.8 Others in Europe
    4.7 Asia & Pacific
        4.7.1 China
        4.7.2 Japan
        4.7.3 India
        4.7.4 Korea
        4.7.5 Australia
        4.7.6 Southeast Asia
            4.7.6.1 Indonesia
            4.7.6.2 Thailand
            4.7.6.3 Philippines
            4.7.6.4 Vietnam
            4.7.6.5 Singapore
            4.7.6.6 Malaysia
            4.7.6.7 Others in Southeast Asia
    4.8 Africa & Middle East
        4.8.1 South Africa
        4.8.2 Egypt
        4.8.3 Turkey
        4.8.4 Saudi Arabia
        4.8.5 Iran
        4.8.6 Others in Africa & Middle East

Chapter Five Dermatology Drug Market by Product Types
    5.1 Dermatology Drug, by Route of Administration 2012-2017
        5.1.1 Global Dermatology Drug Sales Market Share by Route of Administration 2012-2017
        5.1.2 Global Dermatology Drug Revenue Market Share by Route of Administration 2012-2017
        5.1.3 Global Dermatology Drug Price by Route of Administration 2012-2017
        5.1.4 External Use
        5.1.5 Oral
        5.1.6 Injection
    5.2 Dermatology Drug, by Form 2012-2017
        5.2.1 Global Dermatology Drug Sales Market Share by Form 2012-2017
        5.2.2 Global Dermatology Drug Revenue Market Share by Form 2012-2017
        5.2.3 Global Dermatology Drug Price by Form 2012-2017
        5.2.4 Ointment
        5.2.5 Liquid
        5.2.6 Powder
        5.2.7 Spray

Chapter Six Global Key Players Profile
    6.1 AbbVie (U.S.)
        6.1.1 AbbVie (U.S.) Company Details and Competitors
        6.1.2 AbbVie (U.S.) Key Dermatology Drug Models and Performance
        6.1.3 AbbVie (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
        6.1.4 AbbVie (U.S.) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.2 Johnson & Johnson (U.S.)
        6.2.1 Johnson & Johnson (U.S.) Company Details and Competitors
        6.2.2 Johnson & Johnson (U.S.) Key Dermatology Drug Models and Performance
        6.2.3 Johnson & Johnson (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
        6.2.4 Johnson & Johnson (U.S.) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.3 Bayer (Germany)
        6.3.1 Bayer (Germany) Company Details and Competitors
        6.3.2 Bayer (Germany) Key Dermatology Drug Models and Performance
        6.3.3 Bayer (Germany) Dermatology Drug Business SWOT Analysis and Forecast
        6.3.4 Bayer (Germany) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.4 Galderma (Switzerland)
        6.4.1 Galderma (Switzerland) Company Details and Competitors
        6.4.2 Galderma (Switzerland) Key Dermatology Drug Models and Performance
        6.4.3 Galderma (Switzerland) Dermatology Drug Business SWOT Analysis and Forecast
        6.4.4 Galderma (Switzerland) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.5 Bristol-Myers Squibb (U.S.)
        6.5.1 Bristol-Myers Squibb (U.S.) Company Details and Competitors
        6.5.2 Bristol-Myers Squibb (U.S.) Key Dermatology Drug Models and Performance
        6.5.3 Bristol-Myers Squibb (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
        6.5.4 Bristol-Myers Squibb (U.S.) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.6 Novartis (China)
        6.6.1 Novartis (China) Company Details and Competitors
        6.6.2 Novartis (China) Key Dermatology Drug Models and Performance
        6.6.3 Novartis (China) Dermatology Drug Business SWOT Analysis and Forecast
        6.6.4 Novartis (China) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.7 Pfizer (U.S.)
        6.7.1 Pfizer (U.S.) Company Details and Competitors
        6.7.2 Pfizer (U.S.) Key Dermatology Drug Models and Performance
        6.7.3 Pfizer (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
        6.7.4 Pfizer (U.S.) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.8 Merz Pharma (Germany)
        6.8.1 Merz Pharma (Germany) Company Details and Competitors
        6.8.2 Merz Pharma (Germany) Key Dermatology Drug Models and Performance
        6.8.3 Merz Pharma (Germany) Dermatology Drug Business SWOT Analysis and Forecast
        6.8.4 Merz Pharma (Germany) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.9 Valeant (Canada)
        6.9.1 Valeant (Canada) Company Details and Competitors
        6.9.2 Valeant (Canada) Key Dermatology Drug Models and Performance
        6.9.3 Valeant (Canada) Dermatology Drug Business SWOT Analysis and Forecast
        6.9.4 Valeant (Canada) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.10 LEO Pharma (Denmark)
        6.10.1 LEO Pharma (Denmark) Company Details and Competitors
        6.10.2 LEO Pharma (Denmark) Key Dermatology Drug Models and Performance
        6.10.3 LEO Pharma (Denmark) Dermatology Drug Business SWOT Analysis and Forecast
        6.10.4 LEO Pharma (Denmark) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    6.11 GlaxoSmithKline (UK)

Chapter Seven Dermatology Drug by Appliance 2012-2017
    7.1 Global Dermatology Drug Sales Market Share by Appliance 2012-2017
    7.2 Psoriasis
    7.3 Skin Infections
    7.4 Acne
    7.5 Dermatitis
    7.6 Other
    7.7 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
    8.1 Dermatology Drug Industry Chain Structure
        8.1.1 R&D
        8.1.2 Raw Materials (Components)
        8.1.3 Manufacturing Plants
        8.1.4 Regional Trading (Import Export and Local Sales)
        8.1.5 Online Sales Channel
        8.1.6 Offline Channel
        8.1.7 End Users
    8.2 Dermatology Drug Manufacturing
        8.2.1 Key Components
        8.2.2 Assembly Manufacturing
    8.3 Consumer Preference
    8.4 Behavioral Habits
    8.5 Marketing Environment

Chapter Nine Global Dermatology Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global Dermatology Drug Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)
    9.3 Global Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
    9.4 Global Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    9.5 Global Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)

Chapter Ten Development Trend and Research Conclusion
    10.1 Development Trend
    10.2 Research Conclusion

List of Tables and Figures

    Table Global Dermatology Drug Sales Volume (K MT), Revenue (Million USD) and Price (USD/MT)(2012-2017)
    Figure Global Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Dermatology Drug Sales Volume (K MT) and Growth Rate (2012-2017)
    Table Global Dermatology Drug Sales Volume (K MT) by Key Players (2012-2017)
    Table Global Dermatology Drug Sales Volume Market Share by Key Players (2012-2017)
    Figure Global Dermatology Drug Sales Volume Market Share by Key Players 2016
    Figure Global Dermatology Drug Sales Volume Market Share by Key Players 2017
    Table Global Dermatology Drug Revenue (Million USD) by Key Players (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by Key Players (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by Key Players 2016
    Figure Global Dermatology Drug Revenue Market Share by Key Players 2017
    Table Global Key Players Key Product Model and Market Performance
    Table Global Key Players Key Target Consumers and Market Performance
    Table Global Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Global Dermatology Drug Sales Share by Regions (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Regions in 2016
    Figure Global Dermatology Drug Sales Market Share by Regions in 2017
    Table Global Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by Regions (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by Regions in 2016
    Figure Global Dermatology Drug Revenue Market Share by Regions in 2017
    Table Global Dermatology Drug Price (USD/MT) by Regions (2012-2017)
    Table North America Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table North America Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Table North America Dermatology Drug Sales Volume (K MT) by Key Players 2012-2017
    Figure North America Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Latin America Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Latin America Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Table Latin America Dermatology Drug Sales Volume (K MT) by Key Players (2012-2017)
    Figure Latin America Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Europe Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Europe Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Table Europe Dermatology Drug Sales Volume (K MT) by Key Players (2012-2017)
    Figure Europe Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Asia & Pacific Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Asia & Pacific Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific Dermatology Drug Sales Volume (K MT) by Key Players (2012-2017)
    Figure Asia & Pacific Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Africa & Middle East Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Africa & Middle East Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East Dermatology Drug Sales Volume (K MT) by Key Players (2012-2017)
    Figure Africa & Middle East Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Global Dermatology Drug Sales (K MT) by Route of Administration (2012-2017)
    Table Global Dermatology Drug Sales Market Share by Route of Administration (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Route of Administration in 2016
    Table Global Dermatology Drug Revenue (Million USD) by Route of Administration (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by Route of Administration (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by Route of Administration in 2016
    Table Global Dermatology Drug Price (USD/MT) by Route of Administration (2012-2017)
    Table Top Players of External Use Dermatology Drug Products List
    Figure Global External Use Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Players of Oral Dermatology Drug Products List
    Figure Global Oral Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Players of Injection Dermatology Drug Products List
    Figure Global Injection Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Global Dermatology Drug Sales (K MT) by Form (2012-2017)
    Table Global Dermatology Drug Sales Market Share by Form (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Form in 2016
    Table Global Dermatology Drug Revenue (Million USD) by Form (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by Form (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by Form in 2016
    Table Global Dermatology Drug Price (USD/MT) by Form (2012-2017)
    Table Top Players of Ointment Dermatology Drug Products List
    Figure Global Ointment Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Players of Liquid Dermatology Drug Products List
    Figure Global Liquid Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Players of Powder Dermatology Drug Products List
    Figure Global Powder Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Players of Spray Dermatology Drug Products List
    Figure Global Spray Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Global Dermatology Drug Sales (K MT) by  (2012-2017)
    Table Global Dermatology Drug Sales Market Share by  (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by  in 2016
    Table Global Dermatology Drug Revenue (Million USD) by  (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by  (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by  in 2016
    Table Global Dermatology Drug Price (USD/MT) by  (2012-2017)
    Table Global Dermatology Drug Sales (K MT) by  (2012-2017)
    Table Global Dermatology Drug Sales Market Share by  (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by  in 2016
    Table Global Dermatology Drug Revenue (Million USD) by  (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by  (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by  in 2016
    Table Global Dermatology Drug Price (USD/MT) by  (2012-2017)
    Table AbbVie (U.S.) Company Details and Competitors
    Table AbbVie (U.S.) Key Dermatology Drug Models and Performance
    Table AbbVie (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
    Table AbbVie (U.S.) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure AbbVie (U.S.) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AbbVie (U.S.) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure AbbVie (U.S.) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AbbVie (U.S.) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Johnson & Johnson (U.S.) Company Details and Competitors
    Table Johnson & Johnson (U.S.) Key Dermatology Drug Models and Performance
    Table Johnson & Johnson (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
    Table Johnson & Johnson (U.S.) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson (U.S.) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Bayer (Germany) Company Details and Competitors
    Table Bayer (Germany) Key Dermatology Drug Models and Performance
    Table Bayer (Germany) Dermatology Drug Business SWOT Analysis and Forecast
    Table Bayer (Germany) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Bayer (Germany) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bayer (Germany) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Bayer (Germany) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Bayer (Germany) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Galderma (Switzerland) Company Details and Competitors
    Table Galderma (Switzerland) Key Dermatology Drug Models and Performance
    Table Galderma (Switzerland) Dermatology Drug Business SWOT Analysis and Forecast
    Table Galderma (Switzerland) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Galderma (Switzerland) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Galderma (Switzerland) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Galderma (Switzerland) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Galderma (Switzerland) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Bristol-Myers Squibb (U.S.) Company Details and Competitors
    Table Bristol-Myers Squibb (U.S.) Key Dermatology Drug Models and Performance
    Table Bristol-Myers Squibb (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
    Table Bristol-Myers Squibb (U.S.) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Novartis (China) Company Details and Competitors
    Table Novartis (China) Key Dermatology Drug Models and Performance
    Table Novartis (China) Dermatology Drug Business SWOT Analysis and Forecast
    Table Novartis (China) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Novartis (China) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Novartis (China) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Novartis (China) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Novartis (China) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer (U.S.) Company Details and Competitors
    Table Pfizer (U.S.) Key Dermatology Drug Models and Performance
    Table Pfizer (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
    Table Pfizer (U.S.) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Pfizer (U.S.) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer (U.S.) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Merz Pharma (Germany) Company Details and Competitors
    Table Merz Pharma (Germany) Key Dermatology Drug Models and Performance
    Table Merz Pharma (Germany) Dermatology Drug Business SWOT Analysis and Forecast
    Table Merz Pharma (Germany) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Merz Pharma (Germany) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Merz Pharma (Germany) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Merz Pharma (Germany) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Merz Pharma (Germany) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Valeant (Canada) Company Details and Competitors
    Table Valeant (Canada) Key Dermatology Drug Models and Performance
    Table Valeant (Canada) Dermatology Drug Business SWOT Analysis and Forecast
    Table Valeant (Canada) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Valeant (Canada) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Valeant (Canada) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Valeant (Canada) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Valeant (Canada) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table LEO Pharma (Denmark) Company Details and Competitors
    Table LEO Pharma (Denmark) Key Dermatology Drug Models and Performance
    Table LEO Pharma (Denmark) Dermatology Drug Business SWOT Analysis and Forecast
    Table LEO Pharma (Denmark) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure LEO Pharma (Denmark) Dermatology Drug Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure LEO Pharma (Denmark) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure LEO Pharma (Denmark) Dermatology Drug Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure LEO Pharma (Denmark) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline (UK) Company Details and Competitors
    Table Global Dermatology Drug Sales (K MT) by Appliance (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Appliance (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Appliance in 2016
    Figure Global Psoriasis Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Skin Infections Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Acne Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Dermatitis Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Other Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Dermatology Drug Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Dermatology Drug Price (USD/MT) Trend Forecast (2017-2022)
    Table Global Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)
    Table Global Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Dermatology Drug Sales Volume Share Forecast by Regions in 2022
    Table Global Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
    Figure Global Dermatology Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Dermatology Drug Sales Volume Market Share Forecast by Application in 2022
    Table Global Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    Figure Global Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    Figure Global Dermatology Drug Sales Volume Market Share Forecast by Route of Administration in 2022
    Table Global Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)
    Figure Global Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)
    Figure Global Dermatology Drug Sales Volume Market Share Forecast by Form in 2022